Amyloid-beta accumulation

Biomarker

3 papers5 findings

  • Humans2
  • Model organisms1

Interventions

1

Fluphenazine

downin worms1

1 study
  1. Fluphenazine decreases amyloid-beta accumulation in worms.

    “fluphenazine reduced amyloid-beta accumulation”

    Model organismsin a Caenorhabditis elegans model of Alzheimer's disease

    Fluphenazine, an antipsychotic compound, ameliorates Alzheimer's disease by clearing amyloid beta accumulation in C. elegans

    GeroScience9 Sep 2025

More on Fluphenazine

Upstream

1

Age

upin humans1

1 study
  1. Age increases amyloid-beta accumulation in humans.

    “increasing with age in the upper percentiles”

    Humanscognitively unimpaired participantsbrain

    Age-related amyloid beta dynamics modeled with the generalized additive model for location, scale, and shape (GAMLSS) across diverse populations: Cross-sectional trajectories and longitudinal validation

    Alzheimer's & dementia : the journal of the Alzheimer's Association1 Sep 2025

Associations

3

Hyperlipidemia

upin humans1OR 1.83

1 study
  1. Hyperlipidemia is associated with amyloid-beta accumulation in humans (OR = 1.83, p = .047).

    “hyperlipidemia was associated with a 1.8 x higher likelihood of greater than expected Aβ for age (OR = 1.83, p = .047)”

    HumansDown syndromebrainn = 262

    Cardiovascular Risk Composite and Time of Amyloid Accumulation and Cognitive Decline in Down Syndrome Alzheimer's Disease

    AAIC 2025 abstract24 Dec 2025

More on Hyperlipidemia

Cardiovascular risk composite

upin humans1

1 study
  1. Cardiovascular risk composite is associated with amyloid-beta accumulation in humans (r = .156, p = .016).

    “there was a significant positive association between the cardiovascular composite ( r = .156, p = .016) and resistance score; higher cardiovascular composite was associated with greater than expected Aβ for age”

    HumansDown syndromebrainn = 262

    Cardiovascular Risk Composite and Time of Amyloid Accumulation and Cognitive Decline in Down Syndrome Alzheimer's Disease

    AAIC 2025 abstract24 Dec 2025

More on Cardiovascular risk composite

APOE

upin humans1

1 study
  1. APOE is associated with amyloid-beta accumulation in humans.

    “NHWs exhibited steeper Aβ accumulation trajectories, particularly among APOE ε4 carriers.”

    Humanscognitively unimpaired non-Hispanic White vs Korean participantsbrain

    Age-related amyloid beta dynamics modeled with the generalized additive model for location, scale, and shape (GAMLSS) across diverse populations: Cross-sectional trajectories and longitudinal validation

    Alzheimer's & dementia : the journal of the Alzheimer's Association1 Sep 2025

More on APOE

Latest

Nov 2025: 0Dec 2025: 2Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 2Oct 2026: 16 in 12 months